fiasp

Generic: insulin aspart injection

Labeler: novo nordisk
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name fiasp
Generic Name insulin aspart injection
Labeler novo nordisk
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

insulin aspart 100 [iU]/mL

Manufacturer
Novo Nordisk

Identifiers & Regulatory

Product NDC 0169-3205
Product ID 0169-3205_133d5f6e-b40f-47b6-ab47-10dc37114d79
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA208751
Listing Expiration 2026-12-31
Marketing Start 2017-10-20

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01693205
Hyphenated Format 0169-3205

Supplemental Identifiers

RxCUI
1986354 1986356 2205454 2642808 2642809 2730170 2730172 2730174
UNII
D933668QVX
NUI
M0011417 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fiasp (source: ndc)
Generic Name insulin aspart injection (source: ndc)
Application Number BLA208751 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 5 CARTRIDGE in 1 CARTON (0169-3205-15) / 3 mL in 1 CARTRIDGE (0169-3205-11)
  • 5 CARTRIDGE in 1 CARTON (0169-3205-95) / 3 mL in 1 CARTRIDGE (0169-3205-91)
source: ndc

Packages (2)

Ingredients (1)

insulin aspart (100 [iU]/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "133d5f6e-b40f-47b6-ab47-10dc37114d79", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["D933668QVX"], "rxcui": ["1986354", "1986356", "2205454", "2642808", "2642809", "2730170", "2730172", "2730174"], "spl_set_id": ["834e7efc-393f-4c55-9125-628562a8a5cf"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Novo Nordisk"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 CARTRIDGE in 1 CARTON (0169-3205-15)  / 3 mL in 1 CARTRIDGE (0169-3205-11)", "package_ndc": "0169-3205-15", "marketing_start_date": "20191001"}, {"sample": true, "description": "5 CARTRIDGE in 1 CARTON (0169-3205-95)  / 3 mL in 1 CARTRIDGE (0169-3205-91)", "package_ndc": "0169-3205-95", "marketing_start_date": "20191001"}], "brand_name": "Fiasp", "product_id": "0169-3205_133d5f6e-b40f-47b6-ab47-10dc37114d79", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0169-3205", "generic_name": "insulin aspart injection", "labeler_name": "Novo Nordisk", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fiasp", "active_ingredients": [{"name": "INSULIN ASPART", "strength": "100 [iU]/mL"}], "application_number": "BLA208751", "marketing_category": "BLA", "marketing_start_date": "20171020", "listing_expiration_date": "20261231"}